Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole

Neurology

Volumn 51, Issue 6, 1998, Pages 1617-1621

  Read, S J ^a   Hirano, T ^b   Abbott, D F ^b   Sachinidis, J I ^b   Tochon Danguy, H J ^b   Chan, J G ^b   Egan, G F ^b   Scott, A M ^b   Bladin, C F ^b   McKay, W J ^b   Donnan, G A ^b  

^a AUSTIN HEALTH   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; FLUORINE 18; OXYGEN 15; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; ISOTOPE LABELING; MALE; NEUROPATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STROKE; TISSUE DISTRIBUTION;

EID: 0031673805     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.6.1617     Document Type: Article

References (22)

1. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981;12:723-725.
2. Heiss WD, Graf R. The ischemic penumbra. Curr Opin Neurol 1994;7:11-19.
3. Baron JC. Pathophysiology of acute cerebral ischemia: PET studies in humans. Cerebrovasc Dis 1991;1(suppl 1):22-31.
4. Heiss WD, Herholz K. Assessment of pathophysiology of stroke by positron emission tomography. Cerebrovasc Brain Metab Rev 1994;21:455-465.
5. Heiss WD, Huber M, Fink GR, et al. Progressive derangement of peri-infarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992;12:193-203.
6. Marchal G, Beaudouin V, Rioux P, et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke 1996;27:599-606.
7. Nunn A, Linder K, Strauss HW. Nitroimidazoles and imaging hypoxia. Eur J Nucl Med 1995;22:265-280.
8. 18-fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardised myocardium. J Am Coll Cardiol 1990;16:477-485.
9. 18-fluoromisonidazole and positron emission tomography. J Nucl Med 1992;12:2202-2208.
10. 18-fluoromisonidazole. J Nucl Med 1992;33:2133-2137.
11. Abdel-Dayem HM, Scott A, Macapinlac H, Larson S. Tracer imaging in lung cancer. Eur J Nucl Med 1994;21:57-81.
12. 18] fluoromisonidazole. Int J Radiat Oncol Biol Phys 1991;22:199-212.
13. 18 fluoromisonidazole tumor to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma. Eur J Nucl Med 1996;23:1378-1383.
14. Mathias CJ, Welch MJ, Kilbourn MR, et al. Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemia. Life Sci 1987;41:199-206.
15. Yeh SH, Liu RS, Hu HH, et al. Ischemic penumbra in acute stroke: demonstration by PET with fluorine-18 fluoromisonidazole. J Nucl Med 1994;35:205P. Abstract.
16. 18F]fluoromisonidazole). Pharm Res 1994;11:466-469.
17. Kinahan PE, Rogers JG. Analytic 3D image reconstruction using all detected events. IEEE Trans Nucl Sci 1989;36:964-968.
18. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1996;40:216-226.
19. 3H] misonidazole in cerebral ischemia. Stroke 1987;18:168-176.
20. Di Rocco RJ, Kuczynski BL, Pirro JP, et al. Imaging ischemic stroke at risk of infarction during stroke. J Cereb Blood Flow Metab 1993;13:755-762.
21. Barron B, Grotta J, Lamki L, Villar C, Ephron V, Patel D. Preliminary experience with technetium-99m BMS-181321, a nitroimidazole, in the detection of cerebral ischemia associated with acute stroke. J Nucl Med 1996;37(suppl):272P-273P. Abstract.
22. Lythgoe MF, Williams SR, Wiebe LI, McEwan AJB, Gordon I. Autoradiographic imaging of cerebral ischemia using a combination of blood flow and hypoxic markers in an animal model. Eur J Nucl Med 1997;24:16-20.